TVTX
Travere Therapeutics Inc
52.10$
+0.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | +187.3% | +323.8% | -166.5% | – | – | |
| – | +3.3% | -16.6% | +4.7% | +8.6% | +7.6% | +5.9% | +9.5% | +12.6% | +14.9% | +39.0% | -83.2% | – | |
| – | -28.1% | +19.8% | +1.6% | -19.1% | +14.9% | +24.7% | -7.3% | +5.8% | +1.8% | +40.8% | +34.9% | – | |
| – | – | -141.5% | – | – | – | -420.1% | – | – | – | -185.7% | – | – | |
| – | +55,200.0% | +16.9% | +85.5% | -31.7% | +16.7% | +23.3% | -98.0% | -40.4% | +13,374.3% | +17.6% | +0.0% | – | |
| – | -112.7% | – | -72.7% | +61.2% | -274.1% | – | -88.3% | +1,685.4% | -221.1% | – | -1,057.3% | – | |
| – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | |
| – | – | -523.4% | – | -94.1% | +302,332.6% | -97.3% | -60.3% | -4,529.8% | – | -84.2% | +4,360.4% | – | |
| – | -217.3% | – | – | – | +437.3% | -84.8% | +294.3% | +169.9% | -150.0% | – | – | – | |
| – | – | – | – | – | – | – | – | +198.6% | +194.9% | -249.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.